MeCo Diagnostics
San Diego
About MeCo Diagnostics
Clinically validated predictive biomarker platform enabling a new modality of high-efficacy yet low-toxicity cancer therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2024)
- Website: mecodiagnostics.com
- Phone: 5203657431
Industries & Categories
Bioinformatics, Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/meco-diagnostics-54525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.